Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5600 CAD | +9.80% |
|
-3.45% | -20.00% |
| 13/05 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 13/05 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 9.86Cr 8.65Cr 7.97Cr 7.42Cr 14Cr 937.04Cr 14Cr 96Cr 37Cr 459.95Cr 37Cr 36Cr 1.6TCr | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11Cr 10Cr 9.2Cr 8.57Cr 16Cr 1.08TCr 16Cr 110.67Cr 43Cr 531.35Cr 43Cr 42Cr 1.85TCr | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | +9.80% | ||
| 1 week | -3.45% | ||
| 1 month | -6.67% | ||
| 3 months | +40.00% | ||
| 6 months | -20.00% | ||
| Current year | -20.00% |
| 1 week | 0.51 |  | 0.6 |
| 1 month | 0.51 | | 0.68 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.21 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 15/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/04 | Buy | Chief Financial Officer | 1,400 | 0.0006% | ||
| 20/01 | Mindset Capital LLC
| Buy | Company | 50,000 | 0.0200% | |
| 20/01 | Mindset Capital LLC
| Buy | Company | 50,000 | 0.0200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.80% | -3.45% | +3.70% | +143.48% | 9.86Cr | |
| +1.27% | +0.71% | -13.99% | -8.59% | 1.26TCr | |
| +0.61% | +1.31% | -35.65% | -59.61% | 469.32Cr | |
| +1.50% | +3.86% | -10.98% | -13.86% | 435.27Cr | |
| +2.33% | -1.29% | +8.17% | -40.25% | 377.45Cr | |
| +2.98% | +1.05% | +13.17% | -14.61% | 377.22Cr | |
| +1.22% | -16.35% | -14.63% | -22.66% | 304.68Cr | |
| +2.80% | -1.52% | -13.38% | -6.27% | 299.04Cr | |
| +3.15% | -0.20% | -7.61% | -26.86% | 233.75Cr | |
| +3.04% | +0.91% | -11.05% | +24.35% | 165.53Cr | |
| Average | +2.87% | -0.23% | -8.22% | -2.49% | 393.19Cr | |
| Weighted average by Cap. | +1.80% | +0.96% | -10.96% | -19.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.7Cr 2.37Cr 2.18Cr 2.03Cr 3.84Cr 256.86Cr 3.92Cr 26Cr 10Cr 126.08Cr 10Cr 9.92Cr 438.8Cr | 3.24Cr 2.85Cr 2.62Cr 2.44Cr 4.61Cr 308.3Cr 4.7Cr 32Cr 12Cr 151.33Cr 12Cr 12Cr 526.68Cr |
| Net income | -1.13Cr -99.25L -91.35L -85.12L -1.61Cr -107.47Cr -1.64Cr -11Cr -4.26Cr -53Cr -4.24Cr -4.15Cr -183.59Cr | 17.3L 15.19L 13.98L 13.03L 24.57L 16Cr 25.07L 1.68Cr 65.15L 8.07Cr 64.95L 63.54L 28Cr |
| Net Debt | 37.04L 32.52L 29.94L 27.9L 52.61L 35Cr 53.68L 3.6Cr 1.4Cr 17Cr 1.39Cr 1.36Cr 60Cr | 1.53Cr 1.34Cr 1.24Cr 1.15Cr 2.17Cr 145.46Cr 2.22Cr 15Cr 5.76Cr 71Cr 5.74Cr 5.62Cr 248.48Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | CA$0.5600 | +9.80% | 52,019 |
| 29/26/29 | CA$0.5100 | -10.53% | 23,347 |
| 26/26/26 | CA$0.5700 | -3.39% | 29,500 |
| 25/26/25 | CA$0.5900 | +1.72% | 4,000 |
| 24/26/24 | CA$0.5800 | -3.33% | 11,636 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
